These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16549419)

  • 1. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):970-2. PubMed ID: 16549419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.
    Merkies IS; Schmitz PI; van der Meché FG; Samijn JP; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2002 May; 72(5):596-601. PubMed ID: 11971045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI; van der Meché FG; Samijn JP; van Doorn PA;
    Neurology; 2002 Jul; 59(1):84-91. PubMed ID: 12105312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
    Merkies IS; Schmitz PI; Samijn JP; van der Meché FG; van Doorn PA
    Neurology; 1999 Nov; 53(8):1648-54. PubMed ID: 10563607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
    Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
    Eur J Neurol; 2016 Jul; 23(7):1248-53. PubMed ID: 27129110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS.
    Mori K; Hattori N; Sugiura M; Koike H; Misu K; Ichimura M; Hirayama M; Sobue G
    Neurology; 2002 Mar; 58(6):979-82. PubMed ID: 11914423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connecting impairment, disability, and handicap in immune mediated polyneuropathies.
    Merkies IS; Schmitz PI; van der Meché FG; Samijn JP; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):99-104. PubMed ID: 12486276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.
    Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
    Neurology; 2014 Dec; 83(23):2124-32. PubMed ID: 25378677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.
    Garssen MP; Bussmann JB; Schmitz PI; Zandbergen A; Welter TG; Merkies IS; Stam HJ; van Doorn PA
    Neurology; 2004 Dec; 63(12):2393-5. PubMed ID: 15623709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
    Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Lewis RA; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van den Berg LH; van Doorn PA; Cornblath DR; Faber CG; Merkies IS;
    J Peripher Nerv Syst; 2015 Sep; 20(3):277-88. PubMed ID: 26110493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in inflammatory neuropathies: the IN-QoL.
    Draak THP; Faber CG; Merkies ISJ;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.
    Vanhoutte EK; Draak TH; Gorson KC; van Nes SI; Hoeijmakers JG; Van der Pol WL; Notermans NC; Lewis RA; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
    J Peripher Nerv Syst; 2015 Sep; 20(3):289-95. PubMed ID: 26114893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
    Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
    J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
    van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
    Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I
    Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI; Van Der Meché FG; Samijn JP; Van Doorn PA
    Muscle Nerve; 2002 Mar; 25(3):370-7. PubMed ID: 11870713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies.
    Merkies IS; Schmitz PI; Samijn JP; Meché FG; Toyka KV; van Doorn PA
    Muscle Nerve; 2000 Sep; 23(9):1393-401. PubMed ID: 10951442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.